Close Menu

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics reported on Thursday a 200 percent surge in first quarter revenues driven by its collaborative development services activities with pharma partners.

For the three-month period ended March 31, HTG's revenues climbed to $4.2 million from $1.4 million in the same period the year before.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.